shedding noncore assets

Related by string. * shedded . shedder . SHEDDING . Shedding : EUR GBP shedding . shedding crocodile tears . tactfully shedding crocodile tears . unscheduled load shedding / Noncore . NON CORE : divesting noncore assets . divested noncore assets . divest noncore . divest noncore assets / Assets . ASSETS . Assets - [001] : Fifth Third Asset Management . Total Current Assets . Term Asset Backed * *

Related by context. Frequent words. (Click for all words.) 49 shed noncore 48 neurology dermatology 48 faropenem 47 Syntonix 47 Heptares 47 peptide therapeutics 47 exiting unprofitable 47 monoclonal antibody therapeutics 46 nonstrategic assets 46 Chugai Pharmaceutical Japan 46 staphylococcal vaccines 46 therapeutic monoclonal antibodies 45 reallocating resources 45 pharmaceutical intermediates 45 neuro inflammatory 45 antibiotic resistant bacterial infections 44 clinically differentiated 44 HepeX B 44 Diosynth 44 Thiakis 44 regenerative therapeutics 43 Organon Biosciences 43 TaiGen 43 HIV Aids malaria 43 autoimmune inflammatory 43 Chiral Quest 43 ZFP Therapeutics 43 eliminating duplicative 43 endosurgery 43 Hummer Saab 43 HIV AIDS malaria tuberculosis 43 streamlining 42 Divesting 42 IPR intellectual property 42 shedding unprofitable 42 optical biosensors 42 Biopump 42 Accelerating apoptosis may 42 restrictive covenants contained 42 CMV vaccine 42 siRNA therapeutics 42 SXDP 42 oncology infectious diseases 42 Chief Executive Werner Wenning 42 iPSC technology 42 SemEquip 42 biocatalytic 42 SonoLysis 42 ZFP technology 42 Guidant vascular 42 disentangling itself 42 Medigen 41 noncore businesses 41 cardiac contractility 41 biomarker identification 41 preclinical compounds 41 novel anti infective 41 GVAX cancer 41 factor VIIa 41 oncology immunology 41 transfusion transmitted diseases 41 theranostic 41 thetreatment 41 INTERCEPT red 41 Baxa customer 41 consummating acquisitions 41 selective GR 41 lifescience 41 strategy GlobalData summarization 41 commercial bioproduction 41 immunodiagnostics 40 Ligand proprietary 40 theranostics 40 acquisitions divestitures mergers 40 immunotherapeutics 40 novel RNAi therapeutics 40 restructures 40 patented bacterial oxidation 40 outlicense 40 Genetic modification 40 f Represents 40 ALN PCS 40 Diamyd R 40 Solutions Competency recognizes 40 coagulation cascade 40 antibody humanization patents 40 treat gastrointestinal disorders 40 Offer Expires Soon 40 MAXY G# 40 TechniData 40 DII Industries 40 leading lipid nanoparticle 40 corporatewide 40 genomics proteomics biosensors 40 reorganises 40 vosaroxin 40 Inc.ā 40 US#b [002] 40 TBR believes 40 vertically integrating 40 bioproduction

Back to home page